Robuta

Sponsor of the Day: Jerkmate
https://kyvernatx.com/patients/multiple-sclerosis/ Multiple Sclerosis Treatment With CAR T-Cell Therapy | Kyverna Dec 15, 2025 - Discover CAR T-cell therapy for multiple sclerosis. CAR T-cell therapy involves modifying a patient’s T cells to recognize and remove B cells in the patient’s... multiple sclerosis treatmentcell therapycarkyverna https://www.multiplylabs.com/press/kyverna-2025 Multiply Labs Partners with Kyverna Therapeutics | Multiply Labs multiply labspartnerskyvernatherapeutics https://www.statnews.com/2026/04/22/biotech-news-revmed-previews-next-gen-ras-inhibiting-drug/ RevMed, Roche, Kyverna, CAR-T therapy: Readout Newsletter Apr 22, 2026 - Today's biotech news includes CAR-T for autoimmune disease and a regulatory test, RevMed previewing a next-gen RAS inhibiting drug, etc. readout newsletterrochekyvernacartherapy https://kyvernatx.com/patients/systemic-sclerosis/ Systemic Sclerosis (Scleroderma) Treatment With CAR T-Cell Therapy | Kyverna Dec 15, 2025 - Discover CAR T-cell therapy for systemic sclerosis. CAR T-cell therapy involves modifying a patient’s T cells to recognize and remove B cells in the patient’s... cell therapysystemicsclerosissclerodermatreatment